Target intelligence / Profile preview

Abnormal Collagenous Signature Protein (None)

Target: None
Molecular classification: Collagen superfamily, Extracellular matrix protein

Overview

The term "Abnormal Collagenous Signature protein" describes a class of proteins characterized by abnormal structure, expression, or function within the collagen family or related extracellular matrix (ECM) proteins. These abnormalities are often associated with disease states such as cancer, fibrosis, and connective tissue disorders. These proteins are defined by the Gly-X-Y triplet repeat forming a triple helix. Pathogenic mechanisms include misfolding due to mutation, and abnormal expression/remodeling.

Mechanism of action

N/A

Biological functions

Extracellular matrix organizationCell adhesionTissue integrity

Disease associations

Cancer progressionFibrosisKidney diseaseConnective tissue disordersDegenerative joint diseases

Safety considerations

Potential for off-target effects when targeting specific collagen isoformsComplexity of ECM interactions may lead to unpredictable outcomes

Biomarkers

COL1A1/A2 expression in colorectal cancerCOL3A1 expression in colorectal cancerCOL4A3/A6 expression in colorectal cancerMMP2 expression in colorectal cancerType IV/XVIII collagen reduction in kidney tissueType I/III/VI/XV collagen increase in kidney tissue

Beyond the preview

Go deeper on Abnormal Collagenous Signature Protein (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abnormal Collagenous Signature Protein (None).

Explore the full profile